The Jenex Corporation

Jenex is a progressive medical technology company focused on providing consumers with quality dermatological products in the medical device field

Jenex's core philosophy is that clear and healthy skin should not be a privilege for only those who can afford costly procedures and treatments.  The Company's breakthrough proprietary thermal therapy technology uses heat and light energy to deliver effective, non-invasive and pain free skin care.

The Jenex Corporation trades on the NEX (NEX: JEN.H).  Jenex holds the trademarks and regulatory approvals for its thermal therapy technology. 

Latest News

The Jenex Corporation Announces Graduation to the TSX Venture, Update on Chinese Global Financial Forum and Proposed Acquisition
2017-12-12 9:29 AM ET 

The Jenex Corporation Announces Completion of Debt Settlement, Files TherOZap(TM) Device Patent and Presents at Chinese Global Financial Forum
2017-12-04 9:23 AM ET 

The Jenex Corporation Announces AGM Results and Submits Application to Graduate to TSXV
2017-11-23 8:46 AM ET 

The Jenex Corporation Signs Letter of Intent to Acquire Medical Device Assets
2017-11-02 7:00 AM ET 

The Jenex Corporation Reports Promising Initial Results on Zika Virus Testing with TherOZap(TM)

2017-10-12 12:12 PM ET 

The Jenex Corporation Announces Grant of Stock Options

2017-10-06 5:19 PM ET 

The Jenex Corporation Terminates Exclusive License Agreement with Luminar Media Group Inc.
2017-10-02 4:33 PM ET

The Jenex Corporation Announces Approvals of Equity Financing & Move to TSX Venture Exchange (TSXV)
2017-09-19 7:00 AM ET 

Jenex Reports Expected Date of Test Results for TherOZap(TM) at Inactivating the Zika Virus

2017-09-14 4:30 PM ET

The Jenex Corporation Announces Conditional Acceptance of Reactivation from NEX to TSX Venture Exchange, TherOZap(TM) Testing and ISO 13485:2003 Update

2017-08-17 8:57 AM ET

The Jenex Corporation Completes $317,500 Oversubscribed Non-Brokered Private Placement with Insider Participation

2017-06-21 4:26 PM ET

The Jenex Corporation Announces Equity Financing with Insider Participation

2017-05-29 4:18 PM ET

Jenex Finalizing Protocol to Test TherOZap(TM) Against the Zika Virus with University Health Network

2017-05-23 7:00 AM ET

Jenex to Test TherOZap(TM) Working Prototype and Topical Cannabidiol Oil Against the Zika and West Nile Viruses

2017-04-18 9:17 AM ET

Jenex Completes Design of TherOzap(TM) Working Prototype and Signs Service Agreement with University Health Network to Initiate Testing Against the Zika and West Nile Viruses
2017-04-07 9:16 AM ET

 

 

 

+ More